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Abstract 
 
The aim of the present study was to determine the effects of conjugated linoleic acid (CLA) on lipid 
and fatty acid metabolism in Atlantic salmon. The overall objective being to test the hypotheses that 
CLA has beneficial effects in salmon including growth enhancement, improved flesh quality through 
decreased adiposity and lipid deposition thereby minimising detrimental effects of feeding high fat 
diets, and increased nutritional quality through increased levels of beneficial fatty acids including n-3 
highly unsaturated fatty acids (HUFA) and CLA itself.    Salmon smolts were fed diets containing two 
levels of fish oil (low, ~18% and high, ~34%) containing three levels of CLA (a 1:1 mixture of 9-
cis,trans-11 and trans-10,cis-12. at 0, 1 and 2% of diet) for 3 months and the effects on growth 
performance, liver and muscle (flesh) lipid contents and class compositions, and fatty acid 
compositions determined.  The diets were also specifically formulated to investigate whether the effects 
of CLA, if any, were more dependent upon absolute content of CLA in the diet (as percentage of total 
diet) or the relative level of CLA to other fatty acids.   Dietary CLA in salmon smolts had no effect on 
growth parameters or biometric parameters.   However, there was a clear trend of increased total lipid 
and triacylglycerol contents in both liver and flesh in fish fed CLA, particularly in fish fed the high oil 
diets. Finally, CLA was incorporated into tissue lipids, with levels in flesh being 2-fold higher than in 
liver, but importantly, incorporation in liver was at the expense of saturated and monounsaturated fatty 
acids whereas in flesh it was at the expense of n-3HUFA. 
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1. Introduction 
 
 Lipids and their constituent fatty acids are, along with proteins, the major organic constituents of fish, 
with carbohydrates being quantitatively much less prominent in most fish than in mammals (Dabrowski 
and Guderley, 2002).  Indeed the lipid (oil) content of fish can markedly exceed the protein content, 
reflecting the major role lipids and specifically their constituent fatty acids play as sources of   
metabolic energy in fish, for growth including reproduction and movement including migration 
(Tocher, 2003).   Dietary lipid is also required to provide the necessary essential fatty acids (EFA) for 
formation of new cell membranes (Sargent et al., 1989).  Thus lipid and fatty acids can either be 
incorporated into cell membranes and thus the flesh of the fish, or they can be oxidised to provide 
energy, or lipid can be deposited in adipose tissue as an energy store (Tocher, 2003). The more energy 
supplied by dietary lipid, the less dietary protein will be used for energy, and so more protein can be 
“spared” for synthesis of new tissue/flesh (Wilson, 1989; Bell, 1998).  This phenomenon has been 
exploited in aquaculture and, in recent years, technical advances in extruded feed production have 
enabled the lipid or fat content of pelleted diets to increase greatly but, although protein sparing by 
dietary lipid is well documented, the limits to its effectiveness have not been accurately defined for any 
fish species (Company et al., 1999).   Despite this, recent dietary formulations have tended to continue 
the upward trend in dietary lipid, particularly in the case of Atlantic salmon (Salmo salar) (Tocher, 
2003).   In many cases this has successfully increased weight gains, but several studies have shown that 
a potential and, perhaps, detrimental effect of high fat diets is the deposition of excess lipid in tissues, 
specifically flesh in the case of salmon (Sargent et al., 2002; Tocher, 2003).  As well as dietary lipid 
levels, lipid deposition can be related to a number of factors including size, season and disease 
(Shearer, 1994; Sargent et al., 2002). Consequently, it is important to gain a clearer understanding of 
the physiological mechanisms that control energy metabolism, and that determine lipid and fatty acid 
homeostasis in fish.  
         Conjugated linoleic acid (CLA) is a term used to describe positional and geometric isomers of 
linoleic acid (18:2n-6; LA), the two main naturally occurring isomers being cis-9,trans-11 and trans-
10,cis-12, that are known have physiological effects and health benefits including anticarcinogenic and 
immune enhancing properties in mammals (Belury, 2002). However, in addition, CLA also has several 
beneficial effects on lipid metabolism in mammals (DeLany and West, 2000), particularly in relation to 
body composition (Wang and Jones, 2004).  Specifically, CLA decreased body fat and increased lean 
body mass in mice (Ohnuki et al., 2001; Terpstra et al., 2002), rats (Yamasaki et al., 2003) and pigs 
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(Thiel-Cooper et al., 2001; Tischendorf et al., 2002).  Decreased body fat has also been observed in 
human studies (Smedman and Vessby, 2001; Thom et al., 2001; Riserus et al., 2001) although the 
effect was much less than that observed with mice (Terpstra, 2004).    CLA is also known to decrease 
the activity and gene expression of mammalian stearoyl CoA Δ9 desaturase (SCD) (Choi et al., 2001, 
2002) and may also suppress Δ6 and Δ5 desaturase (Chuang et al., 2001a; Eder et al., 2002) and 
elongase (Chuang et al., 2001b).  Further studies have suggested that CLA may enhance growth and 
feed efficiency in young rodents (Pariza et al., 2001) although this has not been consistently observed.   
          The aims of the present study were to determine the effects of CLA on lipid and fatty acid 
composition in Atlantic salmon. The overall objective being to test the hypotheses that CLA has 
beneficial effects in Atlantic salmon including growth enhancement, improved flesh quality through 
decreased adiposity and lipid deposition thereby minimising detrimental effects of feeding high fat 
diets, and increased nutritional quality through increased levels of beneficial fatty acids including n-
3HUFA and CLA itself. In the trial described, salmon smolts were fed diets containing two levels of 
fish oil containing three levels of CLA for three months and the effects on growth performance, liver 
and flesh fat contents and fatty acid compositions determined.   
 
2. Materials and methods 
 
2.1. Diets and Animals 
Photoperiod Atlantic salmon smolts (S1/2) were obtained from a commercial salmonid farm (Howietoun 
Fish Farm, Sauchieburn, Scotland) in late October and transported to the Stirling University, Institute 
of Aquaculture, Marine Environmental Research Laboratory, Machrihanish, Scotland.  The fish were 
maintained in stock tanks for three weeks at ambient water temperature of around 10-11 oC to 
acclimatize during which time the fish were fed standard salmon diet, before being randomly 
distributed between eighteen indoor, round, conical tanks of 1.5m3 volume (1.72m diameter).  The 
initial stocking density was 100 fish of average fish weight 87.5 ± 1.6g per tank (5.8 kg/m3).  Water 
temperature was maintained at 12 oC (±1 oC) throughout the trial, with a light regime of 12L:12D.  Six 
experimental diets were fed to triplicate tanks for 3 months, with feed supplied to appetite manually. 
The experimental diets were formulated to satisfy the nutritional requirements of salmonid fish (U.S. 
National Research Council, 1993), and were formulated and manufactured by BioMar A/S, Brande, 
Denmark.  The trial had a 2 x 3 factorial design with CLA added at three concentrations to diets with 
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two oil contents (low and high).  Thus diets were produced with 0, 1 and 2% CLA replacing standard 
Northern hemisphere fish oil in smolt feeds of containing either 18 or 34% total lipid.  The diets were 
thus formulated to investigate also whether the effects of CLA, if any, were more dependent upon 
absolute content of CLA in the diet (as percentage of total diet) or the relative level of CLA to other 
fatty acids. Diets were formulated to be isonitrogenous and so protein content was constant between 
diets of different oil content (Table 1).  Diets within the low or high oil groups were identical in 
formulation other than fatty acid composition with CLA (LUTA-CLATM 60, containing 60% CLA 
methyl esters as a 50:50 mixture of c9, t11 and t10, c12 isomers; BASF AG, Ludwigshafen, Germany) 
balanced by fish oil (capelin oil, Norsemeal Ltd., London, UK). The fatty acid compositions of the 
diets are presented in Table 2.  
 
2.2. Sampling protocols  
 
       At the initiation and termination of the trial, all the fish in each tank were anaesthetised with 
benzocaine (50mg/L), and bulk weighed.  At the end of the trial, 24 fish per dietary treatment (8/tank) 
were individually weighed and sampled for compositional analyses, with 6 whole fish (2/tank) frozen 
immediately on dry ice for whole body compositional (proximate) analyses. The remaining sampled 
fish were eviscerated and used for biometric determinations (hepato-, and viscero-somatic indices) and 
for tissue lipid analyses.  Flesh samples (Norwegian quality cut) and livers were taken from each fish, 
pooled in six samples of 3 fish each, and frozen immediately in liquid nitrogen (livers) or dry ice 
(flesh).  All samples were subsequently stored at –20 oC prior to analyses.  Six fish per treatment 
(2/tank) were also collected after 1 and 2 months for tissue lipid analyses. 
 
2.3. Proximate analyses (whole body moisture, lipid, protein and ash determinations 
 
     Moisture content of whole fish was determined after drying in an oven at 80 0C for a minimum of 72 
h.  The dried fish samples were then rigorously blended into a homogeneous crumble/meal and used for 
determination of whole body lipid, protein and ash contents.  Lipid content in 1 g samples of dried fish 
crumb was determined using the Soxhlet method with extraction in petroleum ether at 120 oC (Avanti 
Soxtec 2050 Auto Extraction apparatus; Foss, Warrington, UK).  Protein content (N x 6.25) was 
determined in the fish crumble using the automated Kjeldahl method (Tecator Kjeltec Auto 1030 
Analyser; Foss, Warrington, UK). Ash contents were determined after heating portions of the fish 
crumble at 160 oC for 48 h. 
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2.4. Lipid analyses  
 
     Liver and skinned and deboned flesh samples, each consisting of three fish, were homogenised into 
pooled “pates”. Total lipid was extracted from diets or 1g portions of tissue pates by homogenising in 
20 volumes of chloroform/methanol (2:1, v/v) in an Ultra-Turrax tissue disrupter (Fisher Scientific, 
Loughborough, U.K.). Total lipid was prepared according to the method of Folch et al. (1957) and non-
lipid impurities removed by washing with 0.88% (w/v) KCl. The weight of lipid was determined 
gravimetrically after evaporation of solvent and overnight desiccation in vacuo.  Separation of lipid 
classes was performed by high-performance thin-layer chromatography (HPTLC).  Approximately 10 
µg of total lipid was applied as 2 mm streaks and the plate developed to two-thirds distance with 
methyl acetate/isopropanol/ chloroform/methanol/0.25 % aqueous KCl (25:25:25:10:9, by vol.).  After 
desiccation, the plate was fully developed with isohexane/diethyl ether/acetic acid (85:15:1, by vol.).  
The lipid classes were visualised by charring at 160 oC for 15 min after spraying with 3 % (w/v) 
aqueous cupric acetate containing 8 % (v/v) phosphoric acid and quantified by densitometry using a 
Camag 3 TLC Scanner (Camag, Muttenz, Switzerland) and winCATS software (Henderson and 
Tocher, 1992). The identities of individual lipid classes were confirmed by comparison with reference 
to the Rf values of authentic standards run alongside samples on HPTLC plates and developed in the 
above solvent systems. 
        Fatty acid methyl esters (FAME) from diets and tissue total lipid were prepared by acid-catalysed 
transesterification of total lipid according to the method of Christie (1982). Extraction and purification 
of FAME was performed as described by Tocher and Harvie (1988). FAME were separated and 
quantified by gas-liquid chromatography (Carlo Erba Vega 8160, Milan, Italy) using a 30m x 0.32 mm 
i.d. capillary column (CP Wax 52CB, Chrompak, London, U.K.) and on-column injection. Hydrogen 
was used as carrier gas and temperature programming was from 50oC to 150oC at 40oC min-1 and then 
to 230oC at 2.0oC min-1. Individual methyl esters were identified by comparison with known standards 
and by reference to published data (Ackman, 1980; Tocher and Harvie, 1988). Data were collected and 
processed using the Chromcard for Windows (version 1.19) computer package (Thermoquest Italia 
S.p.A., Milan, Italy). 
 
2.5. Materials 
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      BHT was obtained from Sigma Chemical Co. (Poole, U.K.). HPTLC (10 cm x 10 cm x 0.15 mm) 
and TLC (20 cm x 20 cm x 0.25 mm) plates, precoated with silica gel 60 (without fluorescent indicator) 
were obtained from Merck (Darmstadt, Germany).  All solvents were HPLC grade and were obtained 
from Fisher Scientific UK, Loughborough, England. 
 
2.6. Statistical analysis 
 
         All data are presented as means ± SD (n value as stated). Percentage data and data which were 
identified as non-homogeneous (Bartlett’s test) were subjected to arcsine transformation before 
analysis.  The effects of dietary CLA and oil content were determined by two-way analysis of variance 
(ANOVA) with Bonferroni post-tests to determine significance of differences due to CLA. Differences 
were regarded as significant when P < 0.05 (Zar, 1984). 
 
3. Results  
 
3.1. Diet composition 
Inclusion of CLA in the low oil diets resulted in levels of total CLA of 5.9% and 9.5% of total fatty 
acids at the 1 and 2% inclusion levels, respectively (Table 2). Obviously, in the high oil diets, inclusion 
of CLA at 1 and 2% resulted in lower levels of total CLA, at 3.3% and 5.8% of total fatty acids, 
respectively.  Note that the levels of CLA in relative terms were identical in the L1 and H2 diets with 
an overall rank order for CLA content of L2 > L1 = H2 > H1 > L0/H0. 
 
3.2. Growth and biometry 
There were no effects of diet on growth parameters, with no significant effects of CLA or oil content 
on final weights, specific growth rate (SGR) or feed efficiency as measured by feed conversion ratio 
(FCR) (Table 3).  Viscero-somatic (VSI) and hepato-somatic (HSI) indices were both significantly 
increased in fish fed the diets with the high oil content, but dietary CLA had no affect on these 
parameters (Table 3). 
  
3.3. Whole body proximate compositions 
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The composition of whole fish was significantly affected by the oil content of the diet with lipid 
content significantly increased and protein, moisture, ash and protein:lipid ratio all significantly 
reduced in fish fed the high oil diets (Table 4).  Dietary CLA had no significant effects on proximate 
composition of the whole fish.  
 
3.4. Lipid contents and class compositions of liver and flesh 
 
     Liver and flesh (muscle) lipid contents were significantly increased in fish fed the diets containing 
the higher oil content (Table 5).  The increased lipid contents in fish fed the high oil diets were 
reflected in increased proportions of triacylglycerol (TAG) and total neutral lipids in both the liver 
(Table 6) and flesh (Table 7).  Dietary CLA also had an effect on the lipid content of liver and flesh 
with increasing CLA leading to increased lipid content (Table 5).   This effect was more pronounced in 
fish fed the high oil diets and was significant in the case of flesh although it was just short of statistical 
significance in the liver (Table 5).   The increased lipid content in the liver in response to dietary CLA 
was also reflected in increased proportions of TAG and total neutral lipids particularly in the high oil 
diets (Table 6).  Similarly, increased lipid contents in the flesh in response to dietary CLA were 
reflected in increased proportions of TAG and total neutral lipids (Table 7).  The effects of CLA and oil 
content on liver and flesh lipid contents and class compositions as described above were statistically 
significant except for TAG levels in the liver (Table 8). 
 
3.5. Fatty acid compositions of liver and flesh 
 
The fatty acid compositions of total lipid from liver (Table 9) and flesh (Table 10) reflected the fatty 
acid composition of the diets.  Dietary CLA resulted in the deposition of CLA in both tissues with the 
rank order for total CLA in both liver and flesh being L2 > H2 > L1 > H1 > L0/H0 (Tables 9 and 10).  
Accumulation of CLA was 2-fold higher in the flesh, with total CLA in fish fed the L2 diet reaching 
3.4% in the liver (Table 9), and 6.9% in the flesh (Table 10).   CLA deposition in the liver was not at 
the expense of any one particular fatty acid but tended to be spread across several saturated and 
monounsaturated fatty acids (Tables 8 and 9).  In contrast, in the flesh, CLA deposition appeared to be 
primarily at the expense of 20:5n-3 and 22:6n-3 rather than saturated and monounsaturated fatty acids 
(Tables 8 and 10).  It was noteworthy that dietary CLA had no significant effect on the proportions of 
n-6 fatty acids 18:2n-6 or 20:4n-6 in either liver or flesh (Tables 8-10).  Oil content also had an effect 
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on tissue fatty acid compositions with most fatty acids being significantly affected, with fatty acids 
derived from the plant (meal) sources, such as 18:0, 18:1n-9 and 18:2n-6, being reduced and generally 
all the other fatty acids being increased in liver and flesh of fish fed the high oil diets (Tables 8-10). 
 
4. Discussion 
 
The primary aim of the present trial was to determine if dietary CLA had any important effects on lipid 
metabolism and growth parameters in Atlantic salmon.  In a recent study, no effect of dietary CLA on 
growth rate or proximate composition was observed in Atlantic salmon fry fed diets containing up to 
2% CLA (Berge et al., 2004).  Similarly, no effects on weight gain or feed efficiency were noted in 
juvenile yellow perch (Perca flavescens) or catfish (Ictalurus punctatus) fed diets containing up to 1% 
CLA (Twibell et al., 2001; Twibell and Wilson, 2003).  Higher levels of dietary CLA, up to 5% of diet, 
also had no effect on growth or feed efficiency in juvenile tilapia (Oreochromis niloticus) (Yasmin et 
al., 2004). An earlier trial reported that CLA at 0.5% and 0.75% had no effect on growth but at 1% of 
the diet decreased growth in hybrid striped bass (Morone saxatilis x M. chrysops), although there was a 
trend for increased feed efficiency with increased dietary CLA (Twibell et al., 2000). Most of these 
trials used diets with lipid contents in the range 6-12%, which is perhaps too low to fully investigate the 
effects of CLA, if its mechanism of action is through modulation of lipid metabolism and homeostasis 
(refs).  However, the trial on salmon fry used diets containing 24% lipid (Berge et al., 2004), and in the 
trial described here with salmon smolts, lipid levels of up to 34% were used, and still no positive 
effects on growth were obtained.  Overall, therefore the data suggest that dietary CLA does not have 
any beneficial effects on growth performance in fish, including salmon that can tolerate high levels of 
lipid in their diet.  
     Dietary CLA has some beneficial effects on body composition in mammals, with decreased body fat 
and increased lean body mass having been shown in mice, rats and pigs (Ohnuki et al., 2001; Thiel-
Cooper et al., 2001; Terpstra et al., 2002; Tischendorf et al., 2002; Yamasaki et al., 2003).  CLA also 
decreased whole body TAG accumulation in hamsters (Bouthegourd et al., 2002) and reduced liver 
TAG levels in rats (Rahman et al., 2002).  In contrast, similar effects have rarely been observed with 
fish.   No effect on whole body proximate composition was observed with salmon smolts in the present 
trial, or in a previous trial with salmon fry (Berge et al., 2004). Dietary CLA had no significant effect 
on carcass lipid, intraperitoneal fat or liver lipid content in catfish  (Twibell and Wilson, 2003), or on 
tissue lipid contents in tilapia (Yasmin et al., 2004). However, intraperitoneal fat and liver lipid content 
were decreased by dietary CLA in striped bass although, perhaps surprisingly, HSI was increased 
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(Twibell et al., 2000), as it was in yellow perch (Twibell et al., 2001) and in tilapia (Yasmin et al., 
2004).   HSI was not increased in the present trial by dietary CLA, although it was increased in fish fed 
the high oil diets. The increased HSI was associated with increased lipid and TAG content in the liver, 
whereas in the studies on yellow perch and tilapia, increased HSI was not associated with increased 
lipid content and, indeed, liver lipid content was reduced by CLA in striped bass (Twibell et al., 2001; 
Yasmin et al., 2004).  
      In 3T3-L1 adipocytes, CLA suppressed TAG accumulation (Evans et al., 2000) and the t10,c12 
isomer increased fatty acid oxidation (Evans et al., 2002).   CLA inhibited fatty acid synthetase activity 
in rat liver. (Oku et al., 2003), and the t10,c12 isomer attenuated lipogenesis in human AT cells (Brown 
et al., 2001).  Therefore, CLA can affect lipid accumulation both by decreasing synthesis and 
increasing oxidation.  However, to date only gross effects have been measured in fish and the 
biochemical pathways have not been directly studied.   This would also be an interesting area for 
further studies. 
     In the present trial we also aimed to determine if absolute content of CLA in the diet or the level of 
CLA relative to other fatty acids in the diets was more important in eliciting effects, and the diets were 
specifically formulated to this end.  The appropriate formulations were largely achieved and the diets 
provided a graded amount of CLA relative to total fatty acids with diets L1 and H2 supplying around 
the same relative amount of CLA but at two levels of dietary inclusion, 1% and 2%.   The few effects 
made it difficult to be conclusive on the relative importance of absolute or relative amount of dietary 
CLA.  However, the effects of dietary CLA were generally more pronounced in salmon fed the high oil 
diets suggesting that oil content in the diet was important in determining the effects of CLA.  The 
effects of dietary oil content itself were obvious and entirely predictable and consistent with higher 
dietary oil leading to higher deposition of fat in the tissues (Sargent et al., 2002; Tocher 2003). 
     Taking all the studies together, it is clear that dietary CLA has effects on lipid homeostasis in fish.  
However, the effects are not consistent and may vary with species, dependent upon the pattern of lipid 
metabolism which itself varies the species (Tocher 2003).  In addition, patterns of lipid metabolism 
also vary with developmental stage of the fish ands so this may also be important (Tocher 2003. All the 
previous trials used juvenile fish (Twibell et al., 2000,2001; Twibell and Wilson, 2003; Berge et al., 
2004; Yasmin et al., 2004), and the present trial used new smolts, but older, larger salmon that are very 
actively accumulating lipid would be interesting to study.  However, the results obtained may also be 
dependent upon other dietary factors such as lipid content and oil composition, relative level of dietary 
CLA and isomer mix, and duration of the experiment.  Levels of oil used in the trials of CLA in fish 
have varied between 5 and 12%, or up to 24% and 34% in salmon, generally as fish oil, although the 
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precise fish oil varied, and two trials also used diets including a mix of fish oil and vegetable oils such 
as corn oil and soybean oil (Twibell et al., 2000,2001; Twibell and Wilson, 2003; Berge et al., 2004; 
Yasmin et al., 2004).  The levels of CLA varied between 0.5 and 5%, and although all were basically a 
1:1 mix of the two main isomers (c9,t11 and t10,c12), the precise chemical form (free fatty acid, 
methyl esters or triglyceride) were not defined in most of the trials.  
    In mammals, CLA is also known to decrease the activity and gene expression of SCD and may also 
suppress Δ6 and Δ5 desaturases, and elongase (Choi et al., 2001, 2002; Chuang et al., 2001a,b; Eder et 
al., 2002). Dietary CLA increased saturated fatty acids and decreasing 18:1 and C18 PUFA in pig 
muscle and fat (Ramsay et al., 2001), and in chickens it decreased 22:6n-3 in all tissues (Yang et al., 
2003), and increased saturates and decreased monoenes and PUFA in eggs (Szyczyk and Pisulewski 
2003).  The tissue fatty acid composition data in the present study indicated that dietary CLA might 
have some similar effects in salmon.  Thus, there was an indication that SCD in liver was reduced as 
evidenced by increased 18:0 and decreased 18:1n-9, and a similar effect was observed previously in 
salmon fry fed CLA (Berge et al., 2004).  In the present study, it was noteworthy that deposition of 
CLA in flesh was at the expense of n-3HUFA whereas in liver it was at the expense of saturated and 
monounsaturated fatty acids.  Unfortunately, the benefits of CLA-fed fish would be greater if this was 
the other way around and CLA replaced saturated and monounsaturated fatty acids in the flesh.  
Dietary CLA has had rather diverse effects on tissue fatty acid compositions in fish.  Lower 16:1n-7 
was reported in striped bass, and lower monoenes were reported in liver and muscle of yellow perch 
and in tilapia tissues (Twibell et al., 2000,2001; Yasmin  et al., 2004),  In striped bass, CLA increased 
PUFA including 20:5n-3, 22:6n-3 and 18:2n-6 in liver but decreased in muscle (Twibell et al., 2000). 
Total n-3PUFA, especially 22:6n-3, were increased in salmon fry fed CLA (Berge et al., 2004), but 
PUFA were reduced in both liver and muscle in yellow perch (Twibell et al., 2001).  CLA fed to tilapia 
lowered 18:2n-6 but had no effect on 20:4n-6 (Yasmin et al., 2004).  
    In summary, CLA had no effect on growth parameters, but there was a clear trend of increased total 
lipid and TAG contents in both liver and flesh in fish fed CLA, particularly in fish fed the high oil 
diets. CLA was incorporated into tissue lipids, with levels in flesh being 2-fold higher than in liver, but 
importantly, incorporation in liver was at the expense of saturated and monounsaturated fatty acids 
whereas in flesh it was at the expense of n-3HUFA. In conclusion however, the results of the present 
study generally do not support hypotheses that we set out to test.  Thus CLA had few beneficial effects 
in salmon smolts and did not enhance growth parameters or improve flesh quality through decreased 
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adiposity or lipid deposition.  However, salmon fed CLA could be beneficial in the human diet through 
provision of CLA with minimal effect on n-3HUFA levels. 
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Table 1. Formulations (percentage of dry ingredients) and proximate compositions (percentage of total diet) 
of experimental diets
Fishmeal
Sunflower meal
Corn Gluten
Legume seeds
Cereal grains
Micronutrients
Fish oil
CLA
Moisture 8.0 ± 0.3 8.7 ± 0.1 8.9 ± 0.1 3.1 ± 0.1 4.2 ± 0.4 4.4 ± 0.1
Lipid 18.2 ± 0.3 17.4 ± 0.1 16.4 ± 0.5 33.2 ± 0.6 32.4 ± 1.2 32.6 ± 1.6
Protein 44.8 ± 0.1 44.8 ± 0.2 45.8 ± 0.5 47.0 ± 0.3 47.0 ± 0.3 47.1 ± 1.3
Ash 7.8 ± 0.1 7.8 ± 0.1 7.9 ± 0.1 8.2 ± 0.1 8.1 ± 0.0 8.0 ± 0.2
Results for proximate compositions are means ± S.D. (n=3). Micronutrients, incl. essential amino acids 
(methionine and lysine), vitamins, minerals and astaxanthin (Carophyll pink®), Biomar A/S, Brande, Denmark.
H0,H1 and H2, diets containing fish oil at 34% and supplemented with 0, 1 and 2% CLA; 
L0,L1 and L2, diets containing fish oil at 17% and supplemented with 0, 1 and 2% CLA. 
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(CLA) fed to Atlantic salmon (Salmo salar ). 
14:0 5.6 ± 0.2 4.7 ± 0.1 4.3 ± 0.3 6.8 ± 0.3 6.0 ± 0.2 5.8 ± 0.1
16:0 19.6 ± 0.5 18.1 ± 0.7 18.2 ± 0.7 19.9 ± 0.2 19.2 ± 0.2 19.2 ± 0.3
18:0 4.5 ± 0.2 4.5 ± 0.1 5.0 ± 0.4 4.3 ± 0.0 4.4 ± 0.1 4.6 ± 0.1
Total saturated1 30.7 ± 1.0 28.6 ± 1.1 28.9 ± 1.4 31.9 ± 0.4 30.6 ± 0.7 31.0 ± 0.8
16:1n-72 6.7 ± 0.1 5.7 ± 0.2 5.3 ± 3.5 7.5 ± 0.1 6.9 ± 0.1 6.7 ± 0.1
18:1n-9 13.4 ± 0.2 15.1 ± 0.2 17.7 ± 0.6 12.0 ± 0.2 13.1 ± 0.1 14.2 ± 0.0
18:1n-7 2.9 ± 0.1 2.6 ± 0.0 2.5 ± 0.1 3.0 ± 0.1 2.9 ± 0.1 2.9 ± 0.1
20:1n-93 3.0 ± 0.0 2.9 ± 0.3 2.5 ± 0.1 3.2 ± 0.1 2.8 ± 0.0 2.9 ± 0.2
22:1n-114 3.4 ± 0.0 3.1 ± 0.0 2.4 ± 0.1 3.2 ± 0.0 2.9 ± 0.0 2.7 ± 0.0
24:1n-9 0.7 ± 0.1 0.7 ± 0.0 0.6 ± 0.0 0.8 ± 0.0 0.7 ± 0.0 0.7 ± 0.0
Total monoenes 30.1 ± 0.7 30.0 ± 0.7 31.0 ± 0.9 29.8 ± 0.6 29.3 ± 0.4 30.2 ± 0.5
18:2n-6 6.4 ± 0.2 6.6 ± 0.1 6.8 ± 0.2 3.1 ± 0.1 3.3 ± 0.0 3.2 ± 0.0
20:4n-6 0.9 ± 0.0 0.8 ± 0.0 0.7 ± 0.0 1.0 ± 0.1 0.9 ± 0.0 0.8 ± 0.0
CLA (9c,11t) 0.0 ± 0.0 2.9 ± 0.5 4.8 ± 1.6 0.0 ± 0.0 1.6 ± 0.2 2.9 ± 0.7
CLA (10t,12c) 0.0 ± 0.0 3.0 ± 0.4 4.6 ± 1.7 0.0 ± 0.0 1.7 ± 0.4 2.9 ± 0.8
Total n-6 PUFA5 8.4 ± 0.1 14.1 ± 1.0 17.6 ± 3.0 5.1 ± 0.1 8.3 ± 0.7 10.6 ± 1.5
18:3n-3 1.2 ± 0.0 1.1 ± 0.0 1.0 ± 0.0 1.2 ± 0.0 1.2 ± 0.0 1.1 ± 0.0
18:4n-3 2.5 ± 0.1 2.1 ± 0.0 1.8 ± 0.0 2.7 ± 0.0 2.6 ± 0.0 2.3 ± 0.0
20:4n-3 0.7 ± 0.0 0.6 ± 0.0 0.5 ± 0.0 0.8 ± 0.0 0.8 ± 0.0 0.7 ± 0.0
20:5n-3 11.8 ± 0.7 10.2 ± 0.2 8.4 ± 0.5 13.6 ± 0.1 13.0 ± 0.1 11.5 ± 0.1
22:5n-3 1.8 ± 0.1 1.6 ± 0.0 1.3 ± 0.1 2.0 ± 0.0 1.9 ± 0.0 1.7 ± 0.0
22:6n-3 12.7 ± 0.9 11.5 ± 0.5 9.5 ± 0.1 12.9 ± 0.0 12.4 ± 0.2 10.9 ± 0.1
Total n-3 PUFA6 30.8 ± 1.8 27.3 ± 0.8 22.6 ± 0.7 33.2 ± 0.3 31.8 ± 0.4 28.2 ± 0.2
Total PUFA 39.2 ± 1.7 41.5 ± 1.8 40.2 ± 2.4 38.3 ± 0.2 40.13 ± 1 38.8 ± 1.3
Values are means ± SD of 3 samples. 1, contains 15:0, 20:0 and 22:0, present in some samples at up to 0.6%; 
2, contains n-9 isomer; 3, contains n-7 isomer; 4, contains n-9 isomer; 5, totals include 18:3n-6, 20:2n-6 and 22:5n-6 
present in some samples at up to 0.4%; 6, contains 20:3n-3 present at up to 0.2%. H0,H1 and H2, diets containing 
fish oil at 34% and supplemented with 0, 1 and 2% CLA; L0,L1 and L2, diets containing fish oil at 17% and 
supplemented with 0, 1 and 2% CLA. 
Table 2. Fatty acid composition (percentage of weight) of experimental diets containing conjugated linoleic acid 
L0 L1 L2 H0 H1 H2
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Table 3. Growth and biometric parameters  for Atlantic salmon (Salmo salar) fed the experimental diets for three months
CLA Oil Interact.
Initial weight (g) 87.8 ± 1.5 87.4 ± 0.5 87.9 ± 2.2 85.5 ± 1.5 89.3 ± 0.9 86.9 ± 0.6 0.1301 0.4740 0.0506
Final weight (g) 203.2 ± 7.1 199.7 ± 1.8 195.1 ± 12.3 196.1 ± 4.7 201.0 ± 10.1 199.5 ± 1.8 0.7631 0.8964 0.4108
SGR 1.02 ± 0.1 1.01 ± 0.01 0.97 ± 0.05 1.01 ± 0.05 0.99 ± 0.05 1.01 ± 0.02 0.6236 0.8749 0.4712
FCR 1.24 ± 0.1 1.26 ± 0.03 1.32 ± 0.13 1.27 ± 0.07 1.29 ± 0.10 1.28 ± 0.03 0.6547 0.8681 0.7100
VSI 9.20 ± 0.61 9.2 ± 0.80 9.42 ± 0.43 10.87 ± 0.33 10.66 ± 0.52 10.63 ± 0.48 0.9356 0.0001 0.7722
HSI 1.09 ± 0.09 1.12 ± 0.09 1.11 ± 0.06 1.13 ± 0.05 1.20 ± 0.03 1.20 ± 0.02 0.3543 0.0372 0.7742
Data are presented as means ± SD (n =3). CLA, conjugated linoleic acid; FCR, feed conversion ratio = feed consumed (kg )/ weight gain (kg); 
HSI, Hepato-somatic index =100 x liver weight x body weight-1; SGR, specific growth rate (%/day) = 100 x [(Final Weight / Initial Weight)/Days- 1]; 
VSI, Viscero-somatic index = 100 x viscera weight x body weight-1; L0, L1 and L2, low lipid diets with 0, 1 and 2% CLA; H0, H1 and H2, high lipid diets 
with 0, 1 and 2% CLA. Significance (P values) of effects of CLA, oil content and their interaction were determined by two-way ANOVA as described
in the Materials and Methods.
ANOVA
H1 H2L0 L1 L2 H0
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Table  4. Proximate composition of whole Atlantic salmon (Salmo salar ) 
Diet
L0 69.8 ± 1.1 61.2 ± 2.0 29.7 ± 3.1 7.3 ± 0.6 2.06 ± 0.20
L1 70.0 ± 0.6 62.1 ± 2.1 29.4 ± 1.9 7.3 ± 0.7 2.11 ± 0.16
L2 69.9 ± 1.1 61.5 ± 1.7 29.4 ± 2.7 7.2 ± 0.7 2.09 ± 0.17
H0 68.1 ± 0.9 54.9 ± 1.7 35.1 ± 2.1 6.4 ± 0.6 1.56 ± 0.15
H1 68.0 ± 1.3 54.0 ± 1.8 37.3 ± 2.2 6.7 ± 0.9 1.45 ± 0.16
H2 67.5 ± 0.7 53.4 ± 1.4 37.8 ± 1.3 5.9 ± 0.5 1.41 ± 0.11
ANOVA
CLA
Oil
Interact.
Values are means ± SD of 12 fish. Significance (P valuers) of effects of CLA, oil content and 
their interaction were determined two-way ANOVA as described in the Materials and methods.
H0, H1 and H2, diets containing fish oil at 34% and supplemented with 0, 1 and 2% CLA;
L0 ,L1 and L2, diets containing fish oil at 17% and supplemented with 0, 1 and 2% CLA.
< 0.0001
0.4674
0.5281 0.4150
< 0.0001
0.1428 0.0589
0.1676 0.0799 0.4372
< 0.0001
 CLA, conjugated linoleic acid; P:L, protein:lipid ratio.
Moisture Protein Lipid Ash P:L ratio
0.11180.2215
< 0.0001< 0.0001
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Table 5. Lipid content (percentage of wet wt) of liver and flesh from
Atlantic salmon (Salmo salar ) fed CLA
Diet
L0 3.28 ± 0.28 3.12 ± 0.39
L1 3.37 ± 0.14 3.20 ± 0.45
L2 3.45 ± 0.20 3.22 ± 0.41
H0 3.50 ± 0.20 3.90 ± 0.78
H1 3.64 ± 0.20 4.45 ± 0.53
H2 3.76 ± 0.24 4.98 ± 0.23
ANOVA
CLA
Oil
Interact.
Values are means ± SD of 6 samples each of tissue pooled 
from 3 fish. Significance (P values) of effects of CLA, oil content and
their interaction were determined by two -way ANOVA as described
in the Materials and Methods. CLA, conjugated linoleic acid.   
H0, H1 and H2, diets containing fish oil at 34% and supplemented
with 0, 1 and 2% CLA;  L0 ,L1 and L2, diets containing fish oil at 
17% and supplemented with 0, 1 and 2% CLA.
Liver Flesh 
0.0636
0.8762
0.0008
0.0231
 < 0.0001
0.0676
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Table 6. Lipid class composition (percentage of total lipid) of liver of Atlantic salmon (Salmo salar ) fed CLA 
Lipid class
PC 29.8 ± 0.9 28.2 ± 3.8 30.1 ± 2.4 28.2 ± 2.1 25.3 ± 2.2 24.7 ± 1.2
PE 17.1 ± 0.4 17.7 ± 1.0 17.5 ± 0.9 17.5 ± 0.9 15.0 ± 0.6 14.4 ± 0.9
PS 4.1 ± 0.5 4.1 ± 0.8 4.1 ± 0.8 3.6 ± 0.5 3.2 ± 0.2 3.2 ± 0.1
PI 5.8 ± 0.8 6.0 ± 0.7 5.7 ± 0.8 5.6 ± 0.4 5.4 ± 0.3 4.9 ± 0.6
PG/CL 4.7 ± 0.2 4.8 ± 0.4 4.5 ± 0.4 4.5 ± 0.2 3.9 ± 0.3 3.5 ± 0.3
Sphingomyelin 4.8 ± 0.8 4.7 ± 0.9 4.8 ± 0.8 4.2 ± 0.6 3.7 ± 0.3 3.8 ± 0.3
Lyso-PC 0.9 ± 0.6 0.7 ± 0.3 0.8 ± 0.2 0.9 ± 0.4 0.7 ± 0.2 0.7 ± 0.1
Total polar 67.2 ± 3.9 66.2 ± 6.6 67.4 ± 5.8 64.5 ± 3.4 57.2 ± 3.2 55.3 ± 2.2
Total neutral 32.8 ± 3.9 33.8 ± 6.6 32.6 ± 5.8 35.5 ± 3.4 42.8 ± 3.3 44.7 ± 2.2
Cholesterol 18.3 ± 0.9 18.2 ± 1.5 18.8 ± 0.3 18.0 ± 0.6 15.4 ± 1.8 15.1 ± 1.2
Triacylglycerol 12.3 ± 4.7 13.4 ± 8.5 11.9 ± 5.8 15.4 ± 3.8 25.7 ± 4.7 27.3 ± 3.8
Free fatty acid 2.2 ± 0.6 2.1 ± 0.5 1.9 ± 1.0 2.1 ± 1.2 1.7 ± 0.6 2.3 ± 0.7
Steryl ester
Values are means ± SD of 6 samples each of tissue pooled from 3 fish.  CL, cardiolipin; CLA, conjugated linoleic acid; 
PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG, phosphatidylglycerol; PI, phosphatidylinositol; 
PS, phosphatidylserine; trace, < 0.5%. 
L0 H2H1L2 H0L1
tr tr tr tr tr tr
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Table 7. Lipid class composition (percentage of total lipid) of flesh of Atlantic salmon (Salmo salar ) fed CLA
Lipid class
PC 8.6 ± 1.0 8.2 ± 0.6 8.1 ± 1.0 8.0 ± 0.5 7.4 ± 0.5 7.3 ± 0.9
PE 6.9 ± 0.9 6.5 ± 0.9 6.0 ± 0.6 5.6 ± 0.7 5.3 ± 0.5 5.0 ± 0.5
PS 0.8 ± 0.2 0.7 ± 0.2 0.6 ± 0.2 0.5 ± 0.1 0.5 ± 0.1 0.6 ± 0.2
PI 3.4 ± 0.5 3.0 ± 0.5 2.7 ± 0.6 2.2 ± 0.3 2.0 ± 0.2 1.8 ± 0.2
PG/CL 1.4 ± 0.4 1.5 ± 0.5 1.4 ± 0.3 1.2 ± 0.2 1.1 ± 0.2 1.1 ± 0.1
Sphingomyelin 0.6 ± 0.2 0.6 ± 0.2 0.5 ± 0.1 0.4 ± 0.1 0.4 ± 0.0 0.4 ± 0.1
Lyso-PC 2.6 ± 0.4 1.7 ± 0.4 1.6 ± 0.5 1.4 ± 0.4 1.1 ± 0.3 1.0 ± 0.1
Total polar 24.3 ± 2.7 22.3 ± 2.4 20.9 ± 2.8 19.3 ± 1.7 17.6 ± 1.4 17.2 ± 1.7
Total neutral 75.7 ± 2.7 77.7 ± 2.4 79.1 ± 2.8 80.7 ± 1.7 82.4 ± 1.4 82.8 ± 1.7
Cholesterol 9.3 ± 0.3 8.8 ± 0.5 8.7 ± 0.5 8.5 ± 0.7 8.4 ± 0.4 8.3 ± 0.3
Triacylglycerol 53.4 ± 3.0 56.4 ± 3.0 59.5 ± 3.9 62.0 ± 3.4 65.4 ± 2.5 66.0 ± 2.0
Free fatty acid 13.0 ± 1.3 12.5 ± 1.1 11.0 ± 1.1 10.2 ± 2.8 8.6 ± 0.8 8.5 ± 0.4
Values are means ± SD of 6 samples each of tissue pooled from 3 fish.  CL, cardiolipin; CLA, conjugated linoleic acid; 
H1 H2
PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG, phosphatidylglycerol; PI, phosphatidylinositol; 
PS, phosphatidylserine. 
L0 L1 H0L2
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Table 8. Significance (P values) of effects of dietary conjugated linoleic acid (CLA) and 
oil content (Oil), and their interaction (Interact.) as determined by two-way ANOVA as
described in the Methods section.
CLA Oil Iteract. CLA Oil Interact.
Lipid classes
PC 0.0625 0.0002 0.1379 0.1493 0.0086 0.9368
PE 0.0008 < 0.0001 < 0.0001 0.0461 < 0.0001 0.8687
PS 0.5971 0.0002 0.5971 0.7192 0.0072 0.1143
PI 0.216 0.0165 0.5017 0.0107 < 0.0001 0.6688
PG/CL 0.0002 < 0.0001 0.0069 0.9036 0.0075 0.7393
Sphingomyelin 0.535 0.0005 0.6972 0.5852 0.0009 0.5852
Lyso-PC 0.3414 0.7717 0.9181 0.0001 < 0.0001 0.0907
Total polar 0.0341 < 0.0001 0.0441 0.0139 < 0.0001 0.7494
Total neutral 0.0341 < 0.0001 0.0441 0.0139 < 0.0001 0.7494
Cholesterol 0.0154 < 0.0001 0.0036 0.1131 0.0019 0.4941
Triacylglycerol 0.0212 < 0.0001 0.0263 0.0012 < 0.0001 0.5606
Free fatty acids 0.7264 0.9021 0.4793 0.0148 < 0.0001 0.4733
Fatty acids
14:0 0.0042 < 0.0001 0.1530 0.1205 < 0.0001 0.1950
16:0 0.0224 0.0043 0.8540 0.0008 0.0293 0.2091
18:0 0.0238 < 0.0001 0.7143 0.0825 < 0.0001 0.8675
Total saturated 0.2904 0.6673 0.4691 0.0187 0.0112 0.3098
16:1n-7 0.0031 < 0.0001 0.1530 < 0.0001 < 0.0001 0.0649
18:1n-9 0.0146 0.1128 0.8156 0.0008 < 0.0001 0.5323
18:1n-7 0.1530 0.0002 1.000 0.0010 0.0009 0.1304
20:1n-9 0.0649 0.0561 0.0145 0.8284 0.4568 0.1022
22:1n-11 0.1460 0.0004 0.3442 0.1296 0.0979 0.0061
24:1n-9 < 0.0001 1.0000 0.1229 0.2394 1.0000 0.2394
Total monoenes 0.0206 0.1747 0.3679 0.7342 0.4586 0.2031
18:2n-6 0.4345 < 0.0001 0.0932 0.0649 < 0.0001 0.0088
20:4n-6 0.1315 0.5249 0.4930 0.4810 0.0935 0.4810
CLA (9c,11t) < 0.0001 < 0.0001 0.0001 < 0.0001 < 0.0001 < 0.0001
CLA (10t,12c) < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001
18:3n-3 0.0195 < 0.0001 0.2394 < 0.0001 < 0.0001 0.1530
18:4n-3 0.0859 0.0003 0.0859 < 0.0001 < 0.0001 0.2394
20:4n-3 0.3798 < 0.0001 0.3798 0.0003 < 0.0001 0.0195
20:5n-3 0.0851 < 0.0001 0.5323 < 0.0001 < 0.0001 0.1190
22:5n-3 0.1785 < 0.0001 0.1785 0.0006 < 0.0001 0.0712
22:6n-3 0.5863 0.0046 0.3651 0.0018 0.1102 0.6440
Total n-3PUFA 0.138 0.0214 0.2188 0.0002 < 0.0001 0.4302
 CL, cardiolipin; PC, phosphatidylcholine; PE, phosphatidylethanolamine; 
PG, phosphatidylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine;
PUFA, polyunsaturated fatty acids. 
Liver Flesh
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fed conjugated linoleic acid (CLA)
14:0 1.6 ± 0.1 1.5 ± 0.1 1.3 ± 0.2 2.3 ± 0.5 1.8 ± 0.2 1.9 ± 0.2
16:0 18.5 ± 1.3 17.8 ± 1.2 17.1 ± 0.9 19.4 ± 0.9 18.7 ± 0.9 18.4 ± 0.7
18:0 8.3 ± 1.0 8.8 ± 1.1 8.9 ± 0.8 6.3 ± 0.3 7.1 ± 0.4 7.4 ± 0.5
Total saturated1 29.0 ± 1.3 28.8 ± 1.3 27.8 ± 0.7 28.6 ± 1.1 28.2 ± 1.2 28.3 ± 1.2
16:1n-72 2.3 ± 0.1 2.2 ± 0.3 2.0 ± 0.2 3.2 ± 0.5 2.6 ± 0.3 2.6 ± 0.3
18:1n-9 9.6 ± 1.0 8.8 ± 0.4 9.4 ± 0.6 9.4 ± 1.0 8.2 ± 0.8 8.9 ± 0.8
18:1n-7 2.4 ± 0.1 2.3 ± 0.1 2.3 ± 0.1 2.6 ± 0.2 2.5 ± 0.2 2.5 ± 0.1
20:1n-93 1.8 ± 0.2 1.8 ± 0.1 1.6 ± 0.2 2.1 ± 0.4 1.6 ± 0.3 2.0 ± 0.2
22:1n-114 0.5 ± 0.1 0.4 ± 0.3 0.6 ± 0.2 1.0 ± 0.4 0.7 ± 0.2 0.8 ± 0.2
24:1n-9 1.1 ± 0.1 1.0 ± 0.2 0.8 ± 0.1 1.1 ± 0.2 0.9 ± 0.0 0.9 ± 0.1
Total monoenes 17.7 ± 1.5 16.7 ± 1.0 16.6 ± 1.4 19.3 ± 2.4 16.4 ± 1.7 17.6 ± 1.6
18:2n-6 2.8 ± 0.2 2.9 ± 0.2 3.0 ± 0.2 1.9 ± 0.2 1.7 ± 0.2 1.8 ± 0.1
20:4n-6 3.6 ± 0.4 3.7 ± 0.2 3.7 ± 0.2 3.5 ± 0.4 3.9 ± 0.3 3.8 ± 0.3
CLA (9c,11t) 0.0 ± 0.0 0.9 ± 0.2 1.8 ± 0.2 0.0 ± 0.0 0.6 ± 0.1 1.2 ± 0.2
CLA (10t,12c) 0.0 ± 0.0 0.7 ± 0.1 1.6 ± 0.2 0.0 ± 0.0 0.5 ± 0.1 1.0 ± 0.2
Total n-6 PUFA5 7.9 ± 0.4 9.8 ± 0.3 11.7 ± 0.4 6.5 ± 0.3 7.8 ± 0.3 8.9 ± 0.3
18:3n-3 0.4 ± 0.0 0.3 ± 0.1 0.3 ± 0.1 0.5 ± 0.1 0.5 ± 0.1 0.4 ± 0.0
18:4n-3 0.2 ± 0.1 0.2 ± 0.1 0.2 ± 0.1 0.5 ± 0.2 0.3 ± 0.1 0.3 ± 0.1
20:4n-3 0.6 ± 0.1 0.6 ± 0.1 0.6 ± 0.1 1.0 ± 0.1 1.0 ± 0.1 0.9 ± 0.1
20:5n-3 8.4 ± 0.7 8.3 ± 0.6 7.9 ± 0.3 10.2 ± 0.6 10.6 ± 0.3 10.0 ± 0.5
22:5n-3 2.7 ± 0.2 2.5 ± 0.3 2.4 ± 0.1 3.0 ± 0.2 3.1 ± 0.2 2.8 ± 0.1
22:6n-3 33.0 ± 1.3 32.6 ± 0.8 32.5 ± 1.3 30.3 ± 2.3 31.9 ± 1.9 30.7 ± 2.1
Total n-3 PUFA6 45.4 ± 2.0 44.7 ± 0.9 43.9 ± 1.3 45.6 ± 2.5 47.6 ± 1.6 45.3 ± 2.3
Values are means ± SD of 6 samples each of tissue pooled from 3 fish. PUFA, polyunsaturated fatty acids.
1, contains 15:0 and 20:0, present in some samples at up to 0.4%; 2, contains n-9 isomer; 3, contains n-7 isomer;
4, contains n-9 isomer; 5, totals include 18;3n-6, 20:2n-6, 20:3n-6, 22:4n-6 and 22:5n-6 present in some samples at up
to 0.6%; 6, contains 20:3n-3 present at up to 0.1%. H0,H1 and H2, diets containing fish oil at 34% and supplemented 
with 0, 1 and 2% CLA; L0,L1 and L2, diets containing fish oil at 17% and supplemented with 0, 1 and 2% CLA. 
Table 9. Fatty acid composition (percentage of weight) of total lipid from liver of Atlantic salmon (Salmo salar ) 
L0 L1 L2 H0 H1 H2
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fed conjugated linoleic acid (CLA)
14:0 3.8 ± 0.2 3.7 ± 0.6 3.3 ± 0.2 4.2 ± 0.3 4.3 ± 0.3 4.2 ± 0.2
16:0 18.4 ± 0.3 18.1 ± 1.4 16.7 ± 0.4 17.3 ± 0.6 17.5 ± 0.7 16.7 ± 0.5
18:0 5.2 ± 0.2 5.4 ± 0.5 5.3 ± 0.2 4.1 ± 0.2 4.4 ± 0.2 4.3 ± 0.1
Total saturated1 28.2 ± 0.5 28.1 ± 2.5 26.2 ± 0.7 26.3 ± 0.9 26.9 ± 1.1 25.9 ± 0.7
16:1n-72 5.2 ± 0.2 5.2 ± 0.3 4.7 ± 0.1 6.3 ± 0.2 6.2 ± 0.2 6.0 ± 0.2
18:1n-9 14.9 ± 0.4 15.6 ± 0.7 16.0 ± 0.4 14.2 ± 0.8 14.4 ± 0.4 15.0 ± 0.4
18:1n-7 3.3 ± 0.1 3.3 ± 0.2 3.0 ± 0.0 3.4 ± 0.1 3.4 ± 0.2 3.3 ± 0.1
20:1n-93 4.6 ± 0.4 4.8 ± 0.5 4.4 ± 0.2 4.8 ± 0.3 4.5 ± 0.4 4.8 ± 0.5
22:1n-114 3.9 ± 0.4 4.2 ± 0.4 3.8 ± 0.2 4.1 ± 0.3 3.9 ± 0.2 4.0 ± 0.3
24:1n-9 0.7 ± 0.2 0.7 ± 0.2 0.7 ± 0.1 0.8 ± 0.1 0.7 ± 0.1 0.6 ± 0.1
Total monoenes 32.7 ± 1.5 34.0 ± 2.2 32.6 ± 0.8 33.7 ± 1.5 33.1 ± 1.3 33.6 ± 1.1
18:2n-6 5.2 ± 0.2 5.2 ± 0.2 4.9 ± 0.2 3.4 ± 0.1 3.3 ± 0.1 3.4 ± 0.0
20:4n-6 0.8 ± 0.1 0.7 ± 0.1 0.7 ± 0.0 0.8 ± 0.1 0.8 0.1 0.8 ± 0.2
CLA (9c,11t) 0.0 ± 0.0 1.9 ± 0.2 3.7 ± 0.4 0.0 ± 0.0 1.1 ± 0.1 2.2 ± 0.2
CLA (10t,12c) 0.0 ± 0.0 1.6 ± 0.2 3.2 ± 0.4 0.0 ± 0.0 1.0 ± 0.1 2.0 ± 0.2
Total n-6 PUFA5 7.2 ± 0.3 10.5 ± 0.7 13.6 ± 1.0 5.2 ± 0.3 7.3 ± 0.4 9.5 ± 0.5
18:3n-3 1.0 ± 0.0 0.9 ± 0.1 0.8 ± 0.0 1.1 ± 0.0 1.0 ± 0.1 1.0 ± 0.1
18:4n-3 1.4 ± 0.0 1.3 ± 0.1 1.2 ± 0.1 1.8 ± 0.1 1.8 ± 0.1 1.6 ± 0.0
20:4n-3 1.1 ± 0.1 0.9 ± 0.1 0.9 ± 0.0 1.2 ± 0.1 1.2 ± 0.1 1.1 ± 0.0
20:5n-3 7.2 ± 0.3 6.1 ± 1.0 5.9 ± 0.1 8.5 ± 0.5 8.3 ± 0.4 7.6 ± 0.3
22:5n-3 2.8 ± 0.1 2.3 ± 0.4 2.4 ± 0.1 3.2 ± 0.2 3.1 ± 0.2 2.9 ± 0.1
22:6n-3 18.2 ± 1.4 15.5 ± 2.5 16.0 ± 1.3 18.6 ± 1.5 17.0 ± 1.2 16.6 ± 0.5
Total n-3 PUFA6 31.9 ± 1.8 27.4 ± 4.1 27.5 ± 1.2 34.8 ± 2.2 32.6 ± 1.6 31.0 ± 0.8
Values are means ± SD of 6 samples each of tissue pooled from 3 fish. PUFA, polyunsaturated fatty acids.
1, contains 15:0, 20:0 and 22:0, present in some samples at up to 0.5%; 2, contains n-9 isomer; 3, contains n-7 isomer;
4, contains n-9 isomer; 5, totals include 18:3n-6, 20:2n-6, 20:3n-6, 22:4n-6 and 22:5n-6 present in some samples at up to
0.5%; 6, contains 20:3n-3 present at up to 0.5%. H0,H1 and H2, diets containing fish oil at 34% and supplemented with 
0, 1 and 2% CLA; L0,L1 and L2, diets containing fish oil at 17% and supplemented with 0, 1 and 2% CLA. 
Table 10. Fatty acid composition (percentage of weight) of total lipid from flesh of Atlantic salmon (Salmo salar ) 
L0 L1 L2 H0 H1 H2
